Related Experiment Video
Updated: Jul 17, 2026

Assaying Protein Kinase Activity with Radiolabeled ATP
Published on: May 26, 2017
The expression and purification of the N-terminal activation domain of the transcription factor c-Myc: a model
William F Waas1, Kevin N Dalby
1Division of Medicinal Chemistry, College of Pharmacy, University of Texas at Austin, TX 78712, USA.
Abstract:
ERK2 is a mitogen-activated protein kinase (MAPK) that plays pivotal roles in cell signal transduction, where it mediates effects on proliferation and differentiation by growth factors and hormones. An important substrate of ERK2 is the transcription factor c-Myc, which mediates cell cycle progression. The phosphorylation of Ser-62 on c-Myc by ERK2 is thought to contribute to the increased stability of c-Myc during the cell cycle and is thus a critical cellular event. However, the mode of c-Myc recognition by ERK2 is not understood. Early studies by Gupta and Davis concluded that ERK2 specificity determinants are located in residues 1-100 of c-Myc, its activation domain. To pursue both structural and kinetic studies a rapid, but efficient purification method, for the production of the activation domain of c-Myc from an Escherichia coli source, was developed. We chose the minimal number of high-resolution steps to maximize both yield and efficiency without sacrificing purity. Thus, GST-(c-MycDelta2-99)-His(6) was expressed in E. coli, and purified using glutathione-agarose affinity chromatography. Cleavage of the GST fusion protein by thrombin and subsequent purification by nickel-agarose affinity chromatography yielded 8 mg of purified (c-MycDelta2-99)-His(6) from one liter of LB culture. Rigorous characterization demonstrated that under standard assay conditions (c-MycDelta2-99)-His(6) is phosphorylated by ERK2 with the following Michaelis parameters: k(cat)=10.4s(-1), K(M)(c-Myc)=57.4 microM. In summary, a rapid procedure is outlined for the preparation of (c-MycDelta2-99)-His(6) that will be useful for mechanistic and biophysical studies of ERK2.
Insights
Researchers developed an efficient method to purify the c-Myc activation domain for studying its interaction with ERK2, a key enzyme in cell signaling. This purification enables detailed mechanistic and biophysical investigations into how ERK2 recognizes and phosphorylates c-Myc.
Area of Science:
- Molecular Biology
- Biochemistry
- Cell Signaling
Background:
- ERK2 (a MAPK) is crucial for cell signal transduction, influencing proliferation and differentiation.
- ERK2 phosphorylates the transcription factor c-Myc at Ser-62, enhancing its stability and promoting cell cycle progression.
- The precise mechanism of c-Myc recognition by ERK2 remains unclear.
Purpose of the Study:
- To develop a rapid and efficient purification method for the c-Myc activation domain (residues 2-99).
- To enable structural and kinetic studies of the ERK2-c-Myc interaction.
- To facilitate mechanistic and biophysical investigations into ERK2 substrate recognition.
Main Methods:
- Expression of GST-c-Myc(Delta2-99)-His(6) in Escherichia coli.
- Purification using glutathione-agarose and nickel-agarose affinity chromatography.
- Enzymatic characterization of ERK2 phosphorylation of purified c-Myc(Delta2-99)-His(6).
Main Results:
- A high-yield purification protocol yielded 8 mg of (c-MycDelta2-99)-His(6) per liter of culture.
- Kinetic parameters for ERK2 phosphorylation were determined: k(cat)=10.4s(-1) and K(M)(c-Myc)=57.4 microM.
- The developed method provides a reliable source of purified c-Myc activation domain for further studies.
Conclusions:
- A streamlined purification strategy for the c-Myc activation domain has been established.
- This preparation is suitable for detailed mechanistic and biophysical studies of ERK2.
- Understanding ERK2-c-Myc interactions is critical for deciphering cell cycle regulation.
Related Concept Videos
MAPK Signaling Cascades
Master Transcription Regulators
Assembly of Signaling Complexes
Interaction domains in cell signaling
Interaction domains recognize exposed features of their binding partners containing post-translationally modified sequences,...
PI3K/mTOR/AKT Signaling Pathway

